All In MedTech

Device Trial Radar · NCT05585879

Demonstrating Effective Salvage of Inadequate Colonoscopies

Outpatient Colonoscopy: Demonstrating Effective Salvage of Inadequate Colonoscopies Utilizing the Pure-Vu EVS System

Last checked: Nov 21, 2026Latest source record: May 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

16

Actual

Start

Nov 3, 2022

Primary completion

Apr 26, 2024

Study completion Apr 26, 2024

Sponsor

Lead sponsor
Motus GI Medical Technologies LtdNot on our public-company list
Sponsor type
Industry
First posted
Oct 19, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The aim of this study is to demonstrate that the use of the Pure-Vu EVS System can salvage inadequately prepared optical colonoscopies (OCs) to adequate OCs.

Conditions

  • Colorectal Screening

Interventions

  • Pure-Vu EVSDevice

    Subjects will be enrolled until 115 inadequate bowel prep cases via SOC are accrued and subsequently treated with Pure-Vu EVS. Inadequate OCs defined as such if any of the following are met: * Boston Bowel Preparation Score (BBPS) \< 6 (Adequacy is defined as BBPS of 2 or greater in each segment) * Inability to identify \> 5mm polyps

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of incomplete colonoscopiesTime frame: Day 0 (Procedure Day)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • NYU

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.